NCT Number: NCT00239122
Recovery Therapy Trial
This project will systematically apply a specialist version of Cognitive Behaviour Therapy (CBT), known as Recovery Therapy, to a random sample of patients with psychotic disorders. Previously, the therapy has been developed and efficacy established, but the extent of applicability to (unselected) mental health service patients is unknown. The main aim is to establish the extent to which this therapy is acceptable and effective for mental health service clients. A secondary aim is to develop guidelines for the conduct of such therapy in public mental health settings.
Looking for future studies?
Notify MeKey information
Conditions
Age range
16 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Whittlesea Community Mental Health Service, Epping, Victoria, Australia
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- acceptance by the participating Community Mental Health Services for case management
- a preliminary DSM-IV diagnosis of schizophrenia, schizoaffective disorder, mood disorder with psychotic features, or delusional disorder
- a recovery "need" in one of the areas addressed by the therapy
Exclusion criteria
- a preliminary DSM-IV diagnosis of brief psychotic disorder, drug-induced psychosis, mood disorder without hallucinations or delusions, or any other disorder (eg. personality disorder, PTSD) even where psychotic features are/have been present
- non-English speaking
- comorbid intellectual disability
Treatment and study plan
Primary outcomes
-
To determine the applicability of cognitive behaviour therapy for psychosis in the "real world" setting of ordinary mental health services
Secondary outcomes
-
To establish rates of uptake of Recovery Therapy amongst clients at a community mental health service
-
To establish effectiveness of therapy in clients who received a defined length of therapeutic contact (12-24 sessions)
-
To identify factors predicting uptake and effectiveness
Sponsors and collaborators
Lead sponsor
Melbourne Health
Other
Collaborators
- William Buckland Foundation
Registry information
Official study title
Applicability of CBT to Unselected Mental Health Service Clients With Psychotic Disorders
Important dates
- Study start
- 2000
- Study completion
- 2004
- First posted
- Oct 14, 2005
- Registry last updated
- Oct 14, 2005
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
NCT05321602
Antipsychotic Agents, Central Nervous System Depression
Little Rock, Arkansas, United States
View Trial DetailsRelative Bioavailability of LY03010 Compared to Listed Drug
NCT04922593
Antipsychotic Agents, Central Nervous System Depressants
Garden Grove, California, United States
View Trial DetailsBody Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
NCT00312598
Body Weight, Mental Disorders
View Trial DetailsExamining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement
NCT04602741
Mental Disorders, Psychotic Disorders
Toronto, Ontario, Canada
View Trial Details